X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with JUBILANT LIFE SCIENCES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs JUBILANT LIFE SCIENCES - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE JUBILANT LIFE SCIENCES CADILA HEALTHCARE/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 35.9 19.9 180.3% View Chart
P/BV x 9.3 4.2 218.5% View Chart
Dividend Yield % 0.7 0.4 154.0%  

Financials

 CADILA HEALTHCARE   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
JUBILANT LIFE SCIENCES
Mar-14
CADILA HEALTHCARE/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs454187 243.3%   
Low Rs30565 467.7%   
Sales per share (Unadj.) Rs96.1364.3 26.4%  
Earnings per share (Unadj.) Rs14.96.8 217.3%  
Cash flow per share (Unadj.) Rs17.824.5 72.8%  
Dividends per share (Unadj.) Rs3.203.00 106.7%  
Dividend yield (eoy) %0.82.4 35.4%  
Book value per share (Unadj.) Rs52.3164.9 31.7%  
Shares outstanding (eoy) m1,023.74159.28 642.7%   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.90.3 1,142.3%   
Avg P/E ratio x25.518.4 138.7%  
P/CF ratio (eoy) x21.35.1 414.1%  
Price / Book Value ratio x7.30.8 950.3%  
Dividend payout %21.543.8 49.1%   
Avg Mkt Cap Rs m388,45820,061 1,936.4%   
No. of employees `00015.46.2 249.7%   
Total wages/salary Rs m13,31711,052 120.5%   
Avg. sales/employee Rs Th6,371.19,383.0 67.9%   
Avg. wages/employee Rs Th862.41,786.9 48.3%   
Avg. net profit/employee Rs Th986.1176.3 559.3%   
INCOME DATA
Net Sales Rs m98,37658,034 169.5%  
Other income Rs m941191 493.7%   
Total revenues Rs m99,31758,224 170.6%   
Gross profit Rs m23,8295,786 411.8%  
Depreciation Rs m3,0222,812 107.5%   
Interest Rs m4863,237 15.0%   
Profit before tax Rs m21,262-72 -29,489.6%   
Minority Interest Rs m-300-286 104.9%   
Prior Period Items Rs m50-   
Extraordinary Inc (Exp) Rs m-252,145 -1.2%   
Tax Rs m5,716696 820.8%   
Profit after tax Rs m15,2261,090 1,396.4%  
Gross profit margin %24.210.0 242.9%  
Effective tax rate %26.9-965.9 -2.8%   
Net profit margin %15.51.9 823.7%  
BALANCE SHEET DATA
Current assets Rs m44,37629,280 151.6%   
Current liabilities Rs m34,07138,912 87.6%   
Net working cap to sales %10.5-16.6 -63.1%  
Current ratio x1.30.8 173.1%  
Inventory Days Days5484 63.8%  
Debtors Days Days6251 123.0%  
Net fixed assets Rs m47,89655,712 86.0%   
Share capital Rs m1,024155 662.8%   
"Free" reserves Rs m48,74620,968 232.5%   
Net worth Rs m53,51926,265 203.8%   
Long term debt Rs m8,96417,169 52.2%   
Total assets Rs m100,16388,606 113.0%  
Interest coverage x44.71.0 4,576.8%   
Debt to equity ratio x0.20.7 25.6%  
Sales to assets ratio x1.00.7 150.0%   
Return on assets %15.74.9 321.2%  
Return on equity %28.44.2 685.3%  
Return on capital %34.311.6 296.5%  
Exports to sales %45.337.8 119.8%   
Imports to sales %5.916.5 36.0%   
Exports (fob) Rs m44,53721,933 203.1%   
Imports (cif) Rs m5,8389,567 61.0%   
Fx inflow Rs m44,88122,004 204.0%   
Fx outflow Rs m9,06911,749 77.2%   
Net fx Rs m35,81210,255 349.2%   
CASH FLOW
From Operations Rs m19,9388,026 248.4%  
From Investments Rs m-9,039-1,744 518.2%  
From Financial Activity Rs m-9,527-4,447 214.2%  
Net Cashflow Rs m1,3721,834 74.8%  

Share Holding

Indian Promoters % 74.8 45.6 164.0%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 8.3 8.7 95.4%  
FIIs % 5.9 21.2 27.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 21.1 52.1%  
Shareholders   44,069 23,815 185.0%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   DR. REDDYS LAB  STERLING BIOTECH  ASTRAZENECA PHARMA  AUROBINDO PHARMA  SANOFI INDIA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 16, 2017 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS